3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 16.06
-0.06 (-0.37%)
Sep 1, 2026, 4:08 PM HKT
3SBio Market Cap
3SBio has a market cap or net worth of 40.02 billion as of September 1, 2026. Its market cap has decreased by -42.62% in one year.
Market Cap
40.02B
Enterprise Value
25.21B
Revenue
20.63B
Ranking
n/a
PE Ratio
4.28
Stock Price
16.06
ChartMarket Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 40.02B, an increase of 76.57%. That is a compound annual growth rate of 5.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 40.02B | -33.73% |
| Dec 31, 2025 | 60.39B | 321.75% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 99.65B |
| Akeso | 87.83B |
| Genscript Biotech | 76.58B |
| RemeGen | 66.75B |
| Biocytogen Pharmaceuticals (Beijing) | 52.58B |
| Shanghai Henlius Biotech | 38.13B |
| Shanghai Junshi Biosciences | 34.74B |
| InnoCare Pharma | 30.02B |